Atezolizumab plus bevacizumab versus sorafenib or atezolizumab alone for unresectable hepatocellular carcinoma: A systematic review
阿特珠单抗联合贝伐珠单抗对比索拉非尼或阿特珠单抗单药治疗不可切除肝细胞癌:系统评价
期刊:World Journal of Gastrointestinal Oncology
影响因子:2.5
doi:10.4251/wjgo.v13.i11.1813
Ahmed, Faiza; Onwumeh-Okwundu, Jennifer; Yukselen, Zeynep; Endaya Coronel, Maria-Kassandra; Zaidi, Madiha; Guntipalli, Prathima; Garimella, Vamsi; Gudapati, Sravya; Mezidor, Marc Darlene; Andrews, Kim; Mouchli, Mohamad; Shahini, Endrit